![Søren Bregenholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Søren Bregenholt
Amministratore Delegato presso
ALLIGATOR BIOSCIENCE AB
Profilo
Søren Bregenholt currently works at Alligator Bioscience AB, as Chief Executive Officer from 2021, Medicon Valley Alliance FMBA, as Chairman, A Bioscience Incentive AB, as Chairman, Atlas Therapeutics AB, as Chairman, and Oblique Therapeutics AB, as Director.
Dr. Bregenholt also formerly worked at Macrophage Pharma Ltd., as Chief Executive Officer & Director, Novo Nordisk A, as Investment Manager, and Symphogen A, as Chief Operating Officer.
Dr. Bregenholt received his doctorate degree from the University of Copenhagen.
Ultime notizie su Søren Bregenholt
Posizioni attive di Søren Bregenholt
| Società | Posizione | Inizio |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Amministratore Delegato | 01/06/2021 |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Presidente | - |
A Bioscience Incentive AB | Presidente | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Presidente | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Søren Bregenholt
| Società | Posizione | Fine |
|---|---|---|
| NOVO NORDISK A/S | Direttore degli Investimenti | - |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Amministratore Delegato | - |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Direttore operativo | - |
Formazione di Søren Bregenholt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Medicon Valley Alliance FMBA
Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Commercial Services |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Health Technology |
A Bioscience Incentive AB | |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
